Preoperative tumor staging of hepatocellular carcinoma (HCC) is a critical issue that influences tumor recurrence and patient survival in clinical practice. One of the challenges encountered in DWI of the liver is cardiac motion that can affect the accuracy of ADC measurements, which may inevitably influence the performance of DWI for HCC staging. However, the impact of motion for ADC and HCC staging has not been thoroughly investigated. In this work, we quantitatively investigate the relationship of motion correction, ADC and staging of HCC in order to widen the understanding of applications in DWI for tumor assessment.
This abstract and the presentation materials are available to members only; a login is required.